S&P 500 Futures
(-0.81%) 5 008.00 points
Dow Jones Futures
(-0.70%) 37 740 points
Nasdaq Futures
(-0.99%) 17 373 points
Oil
(2.03%) $84.41
Gas
(0.28%) $1.762
Gold
(0.05%) $2 399.20
Silver
(0.11%) $28.41
Platinum
(-0.45%) $950.20
USD/EUR
(0.10%) $0.940
USD/NOK
(0.15%) $11.06
USD/GBP
(0.17%) $0.805
USD/RUB
(-0.17%) $93.74

Realtime updates for MediPal Holdings [MAHLY]

Exchange: OTC Sector: Healthcare Industry: Medical Distribution
Last Updated25 Mar 2024 @ 13:30

0.00% $ 15.45

Live Chart Being Loaded With Signals

Commentary (25 Mar 2024 @ 13:30):

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...

Stats
Today's Volume 1.00
Average Volume 138.00
Market Cap 3.24B
EPS $28.08 ( 2023-09-30 )
Last Dividend $0.185 ( 2021-09-28 )
Next Dividend $0 ( N/A )
P/E 13.43
ATR14 $0 (0.00%)

MediPal Holdings Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MediPal Holdings Financials

Annual 2023
Revenue: $3 360.01B
Gross Profit: $212.12B (6.31 %)
EPS: $184.82
Q3 2023
Revenue: $935.93B
Gross Profit: $61.72B (6.59 %)
EPS: $52.80
Q2 2023
Revenue: $892.25B
Gross Profit: $62.04B (6.95 %)
EPS: $28.08
Q1 2023
Revenue: $886.74B
Gross Profit: $59.34B (6.69 %)
EPS: $52.32

Financial Reports:

No articles found.

MediPal Holdings Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

MediPal Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.56 - low (18.41%) | Divividend Growth Potential Score: 1.065 - No dividend expected
Information
First Dividend $0.191 2021-03-29
Last Dividend $0.185 2021-09-28
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 2 --
Total Paid Out $0.376 --
Avg. Dividend % Per Year 0.00% --
Score 1.71 --
Div. Sustainability Score 3.56
Div.Growth Potential Score 1.065
Div. Directional Score 2.31 --
Next Divdend (Est)
(2024-06-21)
$0 Estimate 0.00 %
Dividend Stability
0.04 Very Bad
Dividend Score
1.71
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RBSPF Ex Dividend Knight 2023-08-10 Semi-Annually 0 0.00%
FFMH Ex Dividend Knight 2023-09-29 Quarterly 0 0.00%
VDMCY Ex Dividend Knight 2023-06-22 Semi-Annually 0 0.00%
LNNGY Ex Dividend Knight 2023-08-23 Annually 0 0.00%
CLZNY Ex Dividend Junior 2023-06-09 Annually 0 0.00%
SCZC Ex Dividend Knight 2023-07-06 Quarterly 0 0.00%
GTPS Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
ANIOY Ex Dividend Knight 2023-07-13 Annually 0 0.00%
YATRF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
MURGY Ex Dividend Junior 2023-05-08 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.01061.5009.7910.00[0 - 0.5]
returnOnAssetsTTM0.01991.2009.3410.00[0 - 0.3]
returnOnEquityTTM0.06461.500-0.393-0.590[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.1980.8009.017.21[1 - 3]
quickRatioTTM0.9280.8009.257.40[0.8 - 2.5]
cashRatioTTM0.1941.500-0.0355-0.0533[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM2 643.151.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM02.0000[0 - 30]
freeCashFlowPerShareTTM02.0000[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.06471.000-2.25-2.25[0.2 - 0.8]
operatingProfitMarginTTM0.01511.000-1.699-1.699[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM1.8720.8000.8540.683[0.5 - 2]
Total Score3.56

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.371.0008.750[1 - 100]
returnOnEquityTTM0.06462.50-0.253-0.590[0.1 - 1.5]
freeCashFlowPerShareTTM02.0000[0 - 30]
dividendYielPercentageTTM0.005161.5009.870[0 - 0.4]
operatingCashFlowPerShareTTM02.0000[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.002741.500-3.320[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score1.065

MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators